N/A (Healthy adults)
Conditions
Interventions
None listed
Sponsors
Meiji Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The Per Protocol Set examined in the other study (UMIN000055373)
Exclusion criteria
Exclusion criteria: Subjects who declined to provide samples and information for this study during the information disclosure period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| concentration of bile acids, secretory IgA, Calprotectin, mucin, zonulin in feces, and its relationship to existing data. | — |
Countries
Japan
Contacts
Public Contactaiko Ishiguro
CPCC Co., Ltd. Business management section
Outcome results
None listed